Imatinib Mesylate Inhibits Platelet-Derived Growth Factor Receptor Phosphorylation of Melanoma Cells But Does Not Affect Tumorigenicity In Vivo

This publication has 20 references indexed in Scilit:

• Incidence of Malignant Melanoma in Auckland, New Zealand: Highest Rates in the World
  World Journal of Surgery, 1999
• Redundancy of autocrine loops in human osteosarcoma cells
  International Journal of Cancer, 1999
• Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
  Physiological Reviews, 1999
• Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis
  The EMBO Journal, 1998
• Expression of fibrogenic cytokines in desmoplastic malignant melanoma
  British Journal of Dermatology, 1998
• CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins
  Blood, 1997
• Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-alpha receptor, but not the PDGF-beta receptor, in human malignant melanoma in vivo
  British Journal of Dermatology, 1996
• Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
  Nature Medicine, 1996
• Oncogenes and the strategy of growth factors
  Cell, 1994
• Correlation of Growth Capacity of Human Tumor Cells in Hard Agarose With Their In Vivo Proliferative Capacity at Specific Metastatic Sites
  JNCI Journal of the National Cancer Institute, 1989